Non-coeliac gluten sensitivity and diagnostic pitfalls

01OverviewDefinition, clinical context and the essential points that orientate the chapter.

The label NCGS is applied to symptoms such as bloating, abdominal pain, altered stool, fatigue, headache or 'brain fog' that improve when wheat or gluten is removed and recur on re-exposure, in the absence of coeliac disease and IgE-mediated wheat allergy. The mechanism is heterogeneous. Gluten may matter for some, while fructans, amylase-trypsin inhibitors, fermentable carbohydrate load, expectation, food processing or an overlapping disorder of gut-brain interaction may dominate in others.

Diagnosis is difficult because starting restriction is itself a test intervention that destroys coeliac evidence. A careful clinician first records baseline symptoms and gluten intake, completes total IgA and coeliac serology and refers when positive or suspicion remains high. Immediate urticaria, angioedema, wheeze, vomiting or exercise-related reactions suggest IgE-mediated wheat allergy and need allergy assessment rather than a home challenge.

After organic alarm conditions are addressed, a short structured trial can be reasonable. Change one exposure at a time, maintain nutrition and predefine which symptoms and functional outcomes count. Reintroduce under dietetic supervision; blinded challenge is mainly a research tool but illustrates why expectation and fructans matter. A patient who tolerates sourdough or small wheat portions may not need a categorical lifelong gluten-free identity.

Key points

Non-coeliac gluten sensitivity describes reproducible intestinal or extra-intestinal symptoms related to wheat or gluten exposure after coeliac disease and wheat allergy are excluded; there is no validated diagnostic biomarker.
Do coeliac serology while gluten is still eaten and complete any required biopsy pathway before restriction, because diet change can normalise both.
Wheat contains fructans and other components, so improvement on a gluten-free diet does not prove gluten itself was the trigger.
IgG food panels, hair analysis, kinesiology and unvalidated direct-to-consumer tests do not diagnose coeliac disease, wheat allergy or NCGS.
Red flags such as weight loss, anaemia, nocturnal diarrhoea, bleeding, fever, family cancer risk or raised inflammatory markers require an organic-disease pathway.
A dietitian-led, time-limited exclusion followed by structured reintroduction reduces unnecessary lifelong restriction and can identify dose tolerance.
The nocebo effect and natural symptom fluctuation are real biological and psychological phenomena, not grounds to dismiss the patient's experience.
Broad gluten-free diets can reduce fibre, whole grains and micronutrients and increase cost; nutritional adequacy is an outcome, not an afterthought.

02AetiologyUnderlying causes, associations and risk factors, with why each one matters.

Wheat-related symptom susceptibility

Symptoms are reproducibly attributed to wheat or gluten after coeliac disease and wheat allergy are excluded, but no validated biomarker defines the syndrome.

Fructan and other wheat components

Fermentable fructans and non-gluten wheat proteins may provoke symptoms, so improvement on a gluten-free diet does not identify the precise trigger.

Gut-brain and expectation effects

Visceral sensitivity, IBS overlap and expectation can amplify genuine symptoms during exposure and withdrawal without implying deliberate fabrication.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.

1
Luminal fermentation
Poorly absorbed wheat fructans draw water and undergo colonic fermentation, producing gas, distension, pain and altered stool in susceptible people.
2
Proposed innate or barrier response
Subtle epithelial and innate immune changes have been reported, but mechanisms are inconsistent and do not support a routine diagnostic test.
3
Absence of coeliac autoimmunity
Unlike coeliac disease, there is no established tissue-transglutaminase-driven villous injury when testing is completed correctly on a gluten-containing diet.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.

Immediate wheat allergyRed flag

Rapid urticaria, angioedema, throat symptoms, wheeze, vomiting, hypotension or exercise-associated reaction after wheat suggests IgE-mediated allergy and can be life-threatening.

Inflammatory or malignant alarmRed flag

Blood in stool, nocturnal diarrhoea, fever, objective weight loss, anaemia, mass, raised calprotectin or new symptoms at an older age requires the appropriate urgent investigation pathway.

Disorder of gut-brain interaction

Chronic pain related to defaecation, variable stool and bloating without alarm features may fit IBS; food sensitivity can coexist without structural injury.

Restriction-related harmRed flag

Continuing weight loss, food fear, an expanding exclusion list, social withdrawal or micronutrient deficiency requires dietetic and possibly eating-disorder assessment.

05InvestigationsWhat to request, why it matters and how to interpret it.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
Coeliac serology with total IgAFirst step
Why
Exclude coeliac disease while the person eats adequate gluten, using IgA tTG and assay-appropriate alternatives in IgA deficiency.
Interpretation and limitations
Negative testing after restriction is not reliable. High pre-test probability, IgA deficiency or discordance may still require specialist biopsy or HLA-informed evaluation.
02
Allergy assessment
Why
Use an allergy-focused history, skin-prick or specific IgE and supervised challenge only through an allergy service when immediate wheat reaction is plausible.
Interpretation and limitations
Sensitisation alone does not equal clinical allergy, and NCGS does not cause IgE-mediated anaphylaxis.
03
Organic-disease screen
Why
Use FBC, ferritin, CRP, renal and liver profile, thyroid tests, faecal calprotectin, stool tests, endoscopy or imaging according to symptoms and alarm features.
Interpretation and limitations
A normal broad panel lowers selected risks but does not create a positive NCGS biomarker.
04
Diet and symptom diary
Why
Record wheat, gluten, fructan and FODMAP exposure alongside pain, bloating, stool form, fatigue and function before changing diet.
Interpretation and limitations
Temporal association generates a hypothesis but is confounded by multiple simultaneous dietary changes and regression to the mean.
05
Structured exclusion and reintroduction
Why
With dietetic support, remove the suspected exposure for a defined period then reintroduce graded amounts while monitoring predefined outcomes.
Interpretation and limitations
Reproducible recurrence supports sensitivity but may not identify gluten as opposed to another wheat component; failure to recur argues against permanent exclusion.
06
Nutrition assessment
Why
Review weight, fibre, iron, folate, B vitamins, calcium, vitamin D, food access and eating behaviour during prolonged restriction.
Interpretation and limitations
Deficiency is a treatment harm signal and may also expose previously unrecognised coeliac or inflammatory disease.

06Differential diagnosisRealistic alternatives and the features that help distinguish them.

Coeliac disease

Positive serology and compatible enteropathy while eating gluten establish coeliac disease; premature restriction can make both tests falsely reassuring.

IgE-mediated wheat allergy

Immediate urticaria, wheeze, angioedema or anaphylaxis after wheat requires allergy assessment rather than a dietary intolerance label.

Irritable bowel syndrome

Symptoms across several fermentable foods and a pain-stool pattern may reflect IBS, with wheat fructans acting as one of multiple triggers.

Additional chapter-specific clues

Probable coeliac mimic

Iron deficiency, osteoporosis, dermatitis herpetiformis, autoimmune disease, first-degree coeliac relative or malabsorptive weight loss increases pre-test probability and requires formal coeliac assessment before restriction.

07ManagementImmediate care, first-line treatment, alternatives and escalation.

01ExcludeBefore gluten restrictionFirst stepA patient attributes recurrent gastrointestinal or systemic symptoms to wheat or gluten.

1Document symptom pattern, current gluten exposure, family and autoimmune risk, immediate allergy features and organic red flags.
2Perform coeliac testing while gluten is consumed and refer positive or high-risk discordant cases; use the allergy pathway for rapid IgE-type reactions.
3Investigate bleeding, weight loss, anaemia, inflammation or nocturnal symptoms through the appropriate NICE or BSG pathway.
4Explain that diet response alone cannot yet distinguish gluten from other wheat components.

02TrialDietitian-led diagnostic trialCoeliac disease, wheat allergy and important organic disease are reasonably excluded, but symptoms remain food-linked.

1Measure baseline symptoms and diet, agree one target change and define a limited trial period with nutritional safeguards.
2Avoid combining gluten-free, dairy-free, low-FODMAP and supplement changes simultaneously because the result becomes uninterpretable.
3Reintroduce gluten or wheat in graded form, or compare fructan-containing foods, when clinically safe and acceptable.
4Use the smallest restriction that controls meaningful symptoms and review whether benefit persists.

03ResetSymptoms persist or restriction expandsA restrictive diet fails, nutritional status worsens or new alarm features emerge.

1Reassess the original coeliac and allergy testing, especially whether adequate gluten was eaten and total IgA measured.
2Investigate IBS, bile acid diarrhoea, lactose intolerance, microscopic colitis, pancreatic disease and inflammatory or malignant causes by phenotype.
3Refer significant weight loss, food fear or compulsive restriction to dietetic and mental-health or eating-disorder support without blame.
4Stop ineffective restrictions gradually and restore dietary diversity while continuing the organic-disease pathway.

08ComplicationsImportant consequences, why they occur and why they matter clinically.

Nutritional restriction

Unsupervised gluten avoidance can reduce fibre, B vitamins, iron and dietary variety and create unnecessary food cost and social burden.

Missed coeliac disease

Starting a gluten-free diet before serology and any required biopsy may suppress diagnostic findings and delay lifelong risk-based management.

Escalating food fear

Attributing broad symptoms to contamination can lead to progressive restriction, weight loss and avoidant eating without improving the underlying gut-brain disorder.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.

Track a small set of patient-defined symptoms and functional outcomes rather than changing the diagnosis after each fluctuating day.
Monitor weight, fibre and key micronutrients during any restriction, especially in pregnancy, older age or multiple exclusions.
Review whether gluten exposure was adequate when coeliac testing occurred and repeat through specialist guidance if the answer is no.
Recheck for bleeding, nocturnal symptoms, fever, anaemia or raised inflammation if the clinical pattern evolves.
Assess diet cost, social participation and anxiety; a symptom benefit that produces major nutritional or psychosocial harm is not a successful plan.
Document the tolerated dose and foods after reintroduction so a temporary trial does not become an indefinite blanket ban.

10Special situationsVariants, exceptions and circumstances that change the usual approach.

Gluten-free also means fructan-low

Removing bread and pasta changes fermentable carbohydrate exposure, food processing and meal pattern at once. Improvement cannot be attributed to gluten automatically.

No biomarker means disciplined method

The absence of a definitive test increases the importance of baseline measurement, exclusion of harm and reproducible reintroduction.

Nocebo is not imaginary

Expectation alters symptom perception and gut physiology. Acknowledging it supports shared experimentation rather than dismissing the patient.

HLA positivity proves little

DQ2 or DQ8 is common in the population and cannot turn diet-responsive symptoms into coeliac disease.

A smaller diet may be better

Many people can reintroduce portions, fermented breads or specific grains. The goal is symptom control with maximum dietary diversity.

11Common pitfallsFrequent interpretation and management errors.

01
Testing coeliac serology only after months gluten-free and calling a negative result exclusion.
02
Using commercial IgG food panels as proof of intolerance.
03
Equating response to wheat avoidance with gluten-specific biology.
04
Missing an immediate allergy phenotype and advising unsupervised re-challenge.
05
Starting several exclusion diets at once.
06
Allowing weight loss and food fear to worsen under the label of healthy eating.